PTC Therapeutics, Inc. (PTCT)
USD 41.88
(-3.15%)
USD 41.88
(-3.15%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.31 Billion USD | -8.68% |
| 2022 | 1.09 Billion USD | 24.15% |
| 2021 | 881.2 Million USD | 15.99% |
| 2020 | 759.69 Million USD | 55.79% |
| 2019 | 487.64 Million USD | 39.96% |
| 2018 | 348.4 Million USD | 37.11% |
| 2017 | 254.1 Million USD | 18.32% |
| 2016 | 214.76 Million USD | 5.33% |
| 2015 | 203.89 Million USD | 66.61% |
| 2014 | 122.37 Million USD | 59.5% |
| 2013 | 76.72 Million USD | 38.02% |
| 2012 | 55.58 Million USD | -18.71% |
| 2011 | 68.37 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 201.66 Million USD | 6.48% |
| 2024 Q1 | 189.4 Million USD | -4.17% |
| 2023 FY | 999.1 Million USD | -8.68% |
| 2023 Q4 | 197.64 Million USD | -35.25% |
| 2023 Q1 | 321.45 Million USD | 1.35% |
| 2023 Q3 | 305.24 Million USD | -5.12% |
| 2023 Q2 | 321.72 Million USD | 0.08% |
| 2022 Q2 | 263.44 Million USD | 11.24% |
| 2022 Q3 | 276.6 Million USD | 4.99% |
| 2022 Q4 | 317.17 Million USD | 14.67% |
| 2022 FY | 1.09 Billion USD | 24.15% |
| 2022 Q1 | 236.82 Million USD | -6.3% |
| 2021 FY | 881.2 Million USD | 15.99% |
| 2021 Q4 | 252.73 Million USD | 17.83% |
| 2021 Q3 | 214.48 Million USD | 3.56% |
| 2021 Q2 | 207.11 Million USD | 0.11% |
| 2021 Q1 | 206.88 Million USD | 1.39% |
| 2020 Q2 | 238.91 Million USD | 52.89% |
| 2020 FY | 759.69 Million USD | 55.79% |
| 2020 Q1 | 156.26 Million USD | 1.93% |
| 2020 Q3 | 160.46 Million USD | -32.83% |
| 2020 Q4 | 204.05 Million USD | 27.16% |
| 2019 Q2 | 115.76 Million USD | 16.72% |
| 2019 Q3 | 119.38 Million USD | 3.12% |
| 2019 FY | 487.64 Million USD | 39.96% |
| 2019 Q1 | 99.18 Million USD | -8.48% |
| 2019 Q4 | 153.3 Million USD | 28.41% |
| 2018 Q3 | 98.52 Million USD | 37.33% |
| 2018 Q4 | 108.37 Million USD | 9.99% |
| 2018 FY | 348.4 Million USD | 37.11% |
| 2018 Q2 | 71.74 Million USD | 2.85% |
| 2018 Q1 | 69.76 Million USD | -0.55% |
| 2017 Q4 | 70.14 Million USD | -1.43% |
| 2017 FY | 254.1 Million USD | 18.32% |
| 2017 Q1 | 52.86 Million USD | 5.34% |
| 2017 Q2 | 59.7 Million USD | 12.94% |
| 2017 Q3 | 71.16 Million USD | 19.2% |
| 2016 Q1 | 57.33 Million USD | -5.9% |
| 2016 FY | 214.76 Million USD | 5.33% |
| 2016 Q3 | 55.05 Million USD | 5.47% |
| 2016 Q4 | 50.18 Million USD | -8.84% |
| 2016 Q2 | 52.19 Million USD | -8.97% |
| 2015 FY | 203.89 Million USD | 66.61% |
| 2015 Q4 | 60.93 Million USD | 17.17% |
| 2015 Q3 | 52 Million USD | 15.58% |
| 2015 Q2 | 44.99 Million USD | 3.49% |
| 2015 Q1 | 43.47 Million USD | -0.81% |
| 2014 Q1 | 23.35 Million USD | 6.06% |
| 2014 FY | 122.37 Million USD | 59.5% |
| 2014 Q3 | 28.39 Million USD | 6.01% |
| 2014 Q4 | 43.83 Million USD | 54.35% |
| 2014 Q2 | 26.78 Million USD | 14.68% |
| 2013 Q3 | 19.73 Million USD | -2.9% |
| 2013 Q4 | 22.02 Million USD | 11.62% |
| 2013 FY | 76.72 Million USD | 38.02% |
| 2013 Q1 | 14.64 Million USD | 22.55% |
| 2013 Q2 | 20.32 Million USD | 38.72% |
| 2012 Q1 | 16.97 Million USD | 0.0% |
| 2012 FY | 55.58 Million USD | -18.71% |
| 2012 Q3 | 13.09 Million USD | -3.43% |
| 2012 Q4 | 11.95 Million USD | -8.74% |
| 2012 Q2 | 13.56 Million USD | -20.1% |
| 2011 FY | 68.37 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -376.63% |
| Alkermes plc | 996.24 Million USD | -31.678% |
| Agenus Inc. | 78.18 Million USD | -1577.907% |
| Aptorum Group Limited | 10.56 Thousand USD | -12415553.984% |
| Ardelyx, Inc. | 169.93 Million USD | -671.955% |
| Dyadic International, Inc. | 9.15 Million USD | -14232.804% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -5795.106% |
| Lantern Pharma Inc. | 17.87 Million USD | -7237.899% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -19386.763% |
| Novavax, Inc. | 779.12 Million USD | -68.373% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -1518.314% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -1495.988% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -6655.604% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -4330.987% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -2369.278% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -244.771% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -5297.043% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -3364.147% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -4163.228% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -1448.513% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -7414.682% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -678.835% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -3909.898% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -720.992% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 27.123% |
| AlloVir, Inc. | 180.93 Million USD | -625.041% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -194.308% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -4319.642% |
| Bicycle Therapeutics plc | 216.92 Million USD | -504.751% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -663.131% |
| ChromaDex Corporation | 56.37 Million USD | -2226.82% |
| Chimerix, Inc. | 93.38 Million USD | -1304.703% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -9331.142% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -771.445% |
| CRISPR Therapeutics AG | 463.49 Million USD | -183.032% |
| Precision BioSciences, Inc. | 92.46 Million USD | -1318.771% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -416.382% |
| Fortress Biotech, Inc. | 200.19 Million USD | -555.28% |
| Fortress Biotech, Inc. | 200.19 Million USD | -555.28% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -3906.102% |
| ImmuCell Corporation | 9.61 Million USD | -13540.31% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -731.256% |
| Immix Biopharma, Inc. | 16.14 Million USD | -8027.308% |
| Incyte Corporation | 1.19 Billion USD | -10.193% |
| Innoviva, Inc. | 132.15 Million USD | -892.659% |
| IO Biotech, Inc. | 91.44 Million USD | -1334.596% |
| Jaguar Health, Inc. | 42.01 Million USD | -3022.309% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -674.965% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -1455.73% |
| ContextLogic Inc. | 387 Million USD | -238.976% |
| MiMedx Group, Inc. | 229.72 Million USD | -471.042% |
| MEI Pharma, Inc. | 34.78 Million USD | -3671.275% |
| NextCure, Inc. | 67.63 Million USD | -1839.527% |
| Onconetix, Inc. | 34.9 Million USD | -3658.048% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -10192.154% |
| Opthea Limited | 191.96 Million USD | -583.365% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -47575.721% |
| Vaxcyte, Inc. | 468.04 Million USD | -180.283% |
| PDS Biotechnology Corporation | 43.04 Million USD | -2947.58% |
| Precigen, Inc. | 84.18 Million USD | -1458.354% |
| Pharming Group N.V. | 225.49 Million USD | -481.77% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -681.661% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -1707.786% |
| PureTech Health plc | 144.59 Million USD | -807.237% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -907.069% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -435.099% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -5297.043% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -473.657% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -4151.071% |
| Acelyrin, Inc. | 422.06 Million USD | -210.815% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -10173918.924% |
| Summit Therapeutics Inc. | 87.68 Million USD | -1396.063% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -3439.386% |
| Senti Biosciences, Inc. | 94.7 Million USD | -1285.183% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -961.761% |
| Elevation Oncology, Inc. | 45.44 Million USD | -2786.65% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -4351.586% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -33178.083% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -892.501% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -3748.725% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -15422.873% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -623.569% |
| Seer, Inc. | 110.49 Million USD | -1087.291% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -1758.285% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -1303.365% |
| ESSA Pharma Inc. | 32.13 Million USD | -3982.385% |
| GlycoMimetics, Inc. | 39.28 Million USD | -3239.26% |
| GT Biopharma, Inc. | 13.57 Million USD | -9562.92% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -496.751% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -552.283% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -405.671% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -2211.242% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -2325.736% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -13100.693% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -225.064% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -6830.308% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -2487.809% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -405.216% |
| Aptose Biosciences Inc. | 52.35 Million USD | -2405.612% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -9003.428% |
| Soligenix, Inc. | 7.79 Million USD | -16728.682% |
| Century Therapeutics, Inc. | 56.07 Million USD | -2239.602% |
| Kura Oncology, Inc. | 165.8 Million USD | -691.198% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -1045.64% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -15669.179% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -52761.758% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -1118.071% |
| Autolus Therapeutics plc | 196.72 Million USD | -566.835% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -1449.592% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -1026.496% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -6667.982% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -307.71% |
| GRI Bio, Inc. | 11.33 Million USD | -11478.447% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -18492.596% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -899.93% |
| IGM Biosciences, Inc. | 265.59 Million USD | -393.932% |
| INmune Bio, Inc. | 29.89 Million USD | -4288.005% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -660.248% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -3154.026% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -8109.577% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -8233.6% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -2012.529% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -1120.065% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -375.833% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -335.175% |
| Verastem, Inc. | 92.08 Million USD | -1324.61% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -7212.771% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -606.334% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -980.529% |
| Histogen Inc. | 14.27 Million USD | -9091.69% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -8074.392% |
| Surrozen, Inc. | 18.55 Million USD | -6971.903% |
| Organovo Holdings, Inc. | 14.91 Million USD | -8695.427% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -25671.654% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -2098.372% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -5014.976% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -2690.788% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -17086.755% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -636.425% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -2607.726% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -435.435% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -8436.958% |
| Apollomics, Inc. | 54.14 Million USD | -2323.048% |
| Amarin Corporation plc | 272.35 Million USD | -381.661% |
| Mesoblast Limited | 5.9 Million USD | -22127.008% |
| Turnstone Biologics Corp. | 78.33 Million USD | -1574.587% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -437.37% |
| Synaptogenix, Inc. | 8.31 Million USD | -15678.94% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -8893.816% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -418.398% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -3835.899% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -14754.525% |
| Exelixis, Inc. | 1.58 Billion USD | 17.327% |
| Better Therapeutics, Inc. | 38.26 Million USD | -3328.566% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -465.326% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -53.395% |
| NLS Pharmaceutics AG | 11.8 Million USD | -11010.621% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -16212.526% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -4273.814% |
| Gritstone bio, Inc. | 148.37 Million USD | -784.143% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1805.052% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -7918.463% |
| Avid Bioservices, Inc. | 25.99 Million USD | -4946.307% |
| Insmed Incorporated | 949.26 Million USD | -38.196% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -8261.094% |
| MediWound Ltd. | 18.86 Million USD | -6852.714% |
| OmniAb, Inc. | 83.89 Million USD | -1463.666% |
| Alector, Inc. | 248.8 Million USD | -427.262% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -459.878% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -2410.647% |
| Zai Lab Limited | 547.47 Million USD | -139.616% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -229.067% |
| Aura Biosciences, Inc. | 84.99 Million USD | -1443.502% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -430.812% |
| Immunic, Inc. | 99.22 Million USD | -1222.111% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -724.993% |
| Veracyte, Inc. | 357.93 Million USD | -266.504% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 85.449% |
| FibroGen, Inc. | 398.11 Million USD | -229.514% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -9131.795% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -18945.414% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -18309.87% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 59.705% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -4970.297% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -314.426% |
| TG Therapeutics, Inc. | 198.47 Million USD | -560.959% |
| Galecto, Inc. | 35.62 Million USD | -3582.146% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -3124.061% |
| Fortrea Holdings Inc. | 457.3 Million USD | -186.866% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -2316.887% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -4442.69% |
| XBiotech Inc. | 37.51 Million USD | -3397.302% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1805.052% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -6253.034% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -823.433% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -1224.086% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -1084.868% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -36.9% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -4447.887% |
| Vaxxinity, Inc. | 56.05 Million USD | -2240.436% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -204.625% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -5780.489% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -1083.254% |
| NexImmune, Inc. | 28.16 Million USD | -4557.274% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -23618.14% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -7231.771% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 53.403% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -5052.748% |
| Scopus BioPharma Inc. | 11.71 Million USD | -11098.052% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -932.439% |
| Ainos, Inc. | 12.95 Million USD | -10027.94% |
| Pluri Inc. | 22.48 Million USD | -5735.578% |
| Prothena Corporation plc | 282.4 Million USD | -364.522% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -555.847% |
| Celularity Inc. | 215.05 Million USD | -509.993% |
| Rallybio Corporation | 78.93 Million USD | -1561.985% |
| Cue Biopharma, Inc. | 19.54 Million USD | -6612.916% |
| MeiraGTx Holdings plc | 151.07 Million USD | -768.318% |
| Omeros Corporation | 94.75 Million USD | -1284.511% |
| Humacyte, Inc. | 23.49 Million USD | -5483.002% |
| Immunocore Holdings plc | 308.04 Million USD | -325.866% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -38597.286% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -1410.203% |
| Blueprint Medicines Corporation | 722.86 Million USD | -81.479% |
| CalciMedica, Inc. | 21.81 Million USD | -5912.917% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -1657.083% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -717.141% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -665.836% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -344.781% |
| Pulmatrix, Inc. | 22.03 Million USD | -5852.618% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -3694.181% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -1376.198% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -137.839% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -1708.16% |
| Cytokinetics, Incorporated | 173.61 Million USD | -655.615% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -3711.377% |
| Nutriband Inc. | 5.73 Million USD | -22778.111% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -2907.906% |
| Vor Biopharma Inc. | 126.03 Million USD | -940.844% |
| Roivant Sciences Ltd. | 1.18 Billion USD | -10.315% |
| Evogene Ltd. | 27.79 Million USD | -4620.54% |
| ProKidney Corp. | 151.52 Million USD | -765.774% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -1668.572% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -16954.04% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -113.575% |
| CorMedix Inc. | 48.95 Million USD | -2579.529% |
| BioLineRx Ltd. | 50.8 Million USD | -2482.257% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -770.496% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -3345.677% |
| Atai Life Sciences N.V. | 125.78 Million USD | -942.921% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -1506.871% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -1511.416% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -419.433% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -3906.836% |
| MediciNova, Inc. | 10.9 Million USD | -11934.918% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -918.35% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -17970.579% |
| GeoVax Labs, Inc. | 6.02 Million USD | -21683.466% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -175.388% |
| Biomea Fusion, Inc. | 126.13 Million USD | -940.027% |
| Mereo BioPharma Group plc | 35.84 Million USD | -3560.058% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -586.506% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -470.478% |
| Absci Corporation | 73.66 Million USD | -1680.792% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -4656.138% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -881.988% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -441.719% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -400.61% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -530.71% |
| Allakos Inc. | 196.05 Million USD | -569.114% |
| Imunon, Inc. | 20.31 Million USD | -6358.939% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -1056.12% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -255.886% |
| BioAtla, Inc. | 129.68 Million USD | -911.542% |
| NLS Pharmaceutics AG | 11.8 Million USD | -11010.621% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -8180.237% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -1444.829% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -3041.525% |
| XOMA Corporation | 46.46 Million USD | -2723.404% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -1080.018% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -820.827% |
| aTyr Pharma, Inc. | 12.97 Million USD | -10007.389% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -1165.569% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -658.858% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -414.923% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -3406.838% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -15849.759% |
| Akari Therapeutics, Plc | 16.8 Million USD | -7705.772% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -57589.327% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -338.276% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -19396.071% |
| UroGen Pharma Ltd. | 138.88 Million USD | -844.529% |
| Sutro Biopharma, Inc. | 243 Million USD | -439.831% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -17933.074% |
| Orgenesis Inc. | 45.75 Million USD | -2766.967% |
| Entera Bio Ltd. | 8.86 Million USD | -14706.298% |
| GH Research PLC | 41.22 Million USD | -3082.373% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -5002.84% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -1479.519% |
| Xencor, Inc. | 306.97 Million USD | -327.341% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -26489.841% |
| Replimune Group, Inc. | 234.77 Million USD | -458.769% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -6302.368% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -583.976% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -19396.071% |
| Portage Biotech Inc. | 18.19 Million USD | -7108.297% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -17970.579% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -1149.834% |
| OncoCyte Corporation | 25.63 Million USD | -5016.972% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -21421.04% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -11350.039% |
| Purple Biotech Ltd. | -22.46 Million USD | 5938.955% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -7860.182% |
| scPharmaceuticals Inc. | 65.17 Million USD | -1912.701% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -15419.685% |
| HilleVax, Inc. | 133.34 Million USD | -883.792% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -12654.866% |
| Tharimmune, Inc. | 9.45 Million USD | -13774.22% |
| Genprex, Inc. | 31.06 Million USD | -4123.484% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -599.55% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -4080.89% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -171382.092% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -23984.037% |
| OKYO Pharma Limited | 8243.57 USD | -15913369.528% |
| Savara Inc. | 15.74 Million USD | -8231.775% |
| Curis, Inc. | 58.35 Million USD | -2148.03% |
| Daré Bioscience, Inc. | 33.6 Million USD | -3803.188% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -25660.257% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -17482.603% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -4754.704% |
| BeiGene, Ltd. | 3.28 Billion USD | 60.085% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -6479.158% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -163.017% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -753.772% |
| Erasca, Inc. | 141.52 Million USD | -826.93% |
| bluebird bio, Inc. | 240.23 Million USD | -446.071% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -28878.253% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 24.878% |
| DBV Technologies S.A. | 92.16 Million USD | -1323.435% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -28878.253% |
| Moderna, Inc. | 6.39 Billion USD | 79.483% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -2978.781% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -9031.547% |
| Molecular Templates, Inc. | 63.09 Million USD | -1979.279% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -1866.744% |
| Travere Therapeutics, Inc. | 472 Million USD | -177.931% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -815.378% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -2013.073% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -2921.693% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -530.297% |
| MacroGenics, Inc. | 217.21 Million USD | -503.935% |
| RenovoRx, Inc. | 11.39 Million USD | -11411.39% |
| Adicet Bio, Inc. | 152.03 Million USD | -762.836% |
| Prime Medicine, Inc. | 186.63 Million USD | -602.875% |
| Aditxt, Inc. | 25.95 Million USD | -4955.103% |
| Adagene Inc. | 41.83 Million USD | -3036.016% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -17845.56% |
| Quantum-Si incorporated | 111.65 Million USD | -1074.861% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -663.362% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -8898.895% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -3562.102% |
| SciSparc Ltd. | 9.01 Million USD | -14458.184% |
| Vericel Corporation | 142.04 Million USD | -823.569% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -15054.082% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -5581.758% |
| Generation Bio Co. | 144.46 Million USD | -808.054% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -1479.957% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -1417.277% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -343.608% |
| Invivyd, Inc. | 205.75 Million USD | -537.573% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -1717.983% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -13887.711% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -1643.214% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -12652.387% |
| 2seventy bio, Inc. | 289.88 Million USD | -352.534% |
| ADMA Biologics, Inc. | 66.58 Million USD | -1870.141% |
| Clene Inc. | 41.07 Million USD | -3093.918% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -10142.424% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -2294.04% |
| GeoVax Labs, Inc. | 6.02 Million USD | -21683.466% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -272.63% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -3471.375% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -3789.463% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -1165.007% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -3925.401% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -670.41% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -70.875% |
| Evaxion Biotech A/S | 22.27 Million USD | -5790.606% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -867.832% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -458.509% |
| Trevena, Inc. | 38.41 Million USD | -3315.089% |
| Surrozen, Inc. | 18.55 Million USD | -6971.903% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -1540.926% |
| Cingulate Inc. | 22.75 Million USD | -5663.993% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 17609.851% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -2836.929% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -15832.079% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -1179.118% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -73.964% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -2013.345% |
| Clearmind Medicine Inc. | 8.74 Million USD | -14907.27% |
| Kronos Bio, Inc. | 128.11 Million USD | -923.93% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -1460.374% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -44627.061% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -1201.078% |
| Statera Biopharma, Inc. | 28.82 Million USD | -4450.331% |
| ImmunityBio, Inc. | 362.87 Million USD | -261.515% |
| Korro Bio, Inc. | 84.53 Million USD | -1451.847% |
| Kineta, Inc. | 21.15 Million USD | -6100.785% |
| BioVie Inc. | 31.95 Million USD | -4005.883% |
| Codexis, Inc. | 66.51 Million USD | -1872.155% |
| Celularity Inc. | 215.05 Million USD | -509.993% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -478.869% |
| Celcuity Inc. | 66.23 Million USD | -1880.721% |
| Virax Biolabs Group Limited | 6.54 Million USD | -19937.046% |
| Cibus, Inc. | 320.3 Million USD | -309.559% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -2950.786% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -3776.132% |
| IN8bio, Inc. | 30.33 Million USD | -4224.218% |
| Kodiak Sciences Inc. | 277.32 Million USD | -373.04% |
| Annexon, Inc. | 143.72 Million USD | -812.754% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -928.159% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -5626.3% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -204874.688% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -68.273% |
| Eyenovia, Inc. | 25.4 Million USD | -5063.406% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -834.924% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -23485.725% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -1557.764% |
| Arcellx, Inc. | 200.19 Million USD | -555.267% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -2758.035% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -506.179% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -13075.033% |
| Moolec Science SA | 52.75 Million USD | -2386.868% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -2045.7% |
| Geron Corporation | 70.44 Million USD | -1762.322% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -2718.732% |
| Royalty Pharma plc | 862.4 Million USD | -52.114% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -1294.504% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -13963.645% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -5697.274% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -531.262% |
| Humacyte, Inc. | 23.49 Million USD | -5483.002% |
| Structure Therapeutics Inc. | 102.77 Million USD | -1176.417% |
| 89bio, Inc. | 151.2 Million USD | -767.595% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -1537.096% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -8922.27% |
| Genelux Corporation | 24.33 Million USD | -5290.746% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -3767.105% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -658.862% |
| Notable Labs, Ltd. | 14.77 Million USD | -8781.774% |
| Liquidia Corporation | 87.98 Million USD | -1390.996% |
| Mustang Bio, Inc. | 48.5 Million USD | -2604.765% |
| Immunovant, Inc. | 282.7 Million USD | -364.024% |
| Quantum-Si incorporated | 111.65 Million USD | -1074.861% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -5719.012% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -6068.421% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -1185.964% |
| Acasti Pharma Inc. | 11.3 Million USD | -11508.159% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -5623.276% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -8109.577% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -2718.611% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -115523.226% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -8157.824% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -4399.221% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -3069.916% |
| PepGen Inc. | 84.76 Million USD | -1447.599% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -4327.248% |
| United Therapeutics Corporation | 885.1 Million USD | -48.214% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -5629.301% |
| Solid Biosciences Inc. | 104.31 Million USD | -1157.574% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -3908.607% |
| Immuneering Corporation | 58.41 Million USD | -2145.802% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -25671.654% |
| Silo Pharma, Inc. | 3.92 Million USD | -33349.418% |
| Belite Bio, Inc | 31.66 Million USD | -4042.472% |
| XOMA Corporation | 46.46 Million USD | -2723.404% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -1842.025% |
| Bionomics Limited | 17.89 Billion USD | 92.668% |
| Apogee Therapeutics, Inc. | 93 Million USD | -1310.533% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 3776.676% |
| uniQure N.V. | 285.08 Million USD | -360.155% |
| Cassava Sciences, Inc. | 105.95 Million USD | -1138.085% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -17845.56% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -575.484% |
| Forte Biosciences, Inc. | 32.47 Million USD | -3939.283% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -15688.623% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -4362.793% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -23485.725% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -9131.795% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -14657.993% |
| Altimmune, Inc. | 30.55 Million USD | -4193.226% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -206.754% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 3776.676% |
| Compugen Ltd. | 43.97 Million USD | -2883.416% |
| Peak Bio, Inc. | 1249.13 USD | -105020034.013% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -1669.884% |
| Benitec Biopharma Inc. | 22.38 Million USD | -5761.129% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -439.431% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -4496.006% |
| Zura Bio Limited | 62.63 Million USD | -1994.317% |
| PolyPid Ltd. | 21.04 Million USD | -6133.49% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -7959.953% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -4496.006% |
| Instil Bio, Inc. | 85.78 Million USD | -1429.216% |
| argenx SE | 1.53 Billion USD | 14.456% |
| Immunome, Inc. | 122.82 Million USD | -968.098% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -2606.327% |
| Verona Pharma plc | 67.15 Million USD | -1853.556% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -4967.947% |
| Shattuck Labs, Inc. | 93.61 Million USD | -1301.327% |
| CervoMed Inc. | 14.95 Million USD | -8670.28% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -1755.421% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -15253.909% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -2472.231% |
| Moolec Science SA | 52.75 Million USD | -2386.868% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -7875.455% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -889.655% |
| AnaptysBio, Inc. | 181.56 Million USD | -622.505% |
| Design Therapeutics, Inc. | 78.19 Million USD | -1577.757% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -1407.15% |
| NeurAxis, Inc. | 8.82 Million USD | -14771.425% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -10323.822% |
| Lumos Pharma, Inc. | 38.66 Million USD | -3292.831% |
| Achilles Therapeutics plc | 75.25 Million USD | -1643.19% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -4967.947% |
| 180 Life Sciences Corp. | 13.47 Million USD | -9633.541% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -4849.876% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -44627.061% |
| Nutriband Inc. | 5.73 Million USD | -22778.111% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -1084.183% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -2257.174% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -2478.349% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -1884.656% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -2323.804% |
| Palisade Bio, Inc. | 13.32 Million USD | -9748.634% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -2788.938% |
| Beam Therapeutics Inc. | 554.19 Million USD | -136.711% |
| Neurogene Inc. | 55.58 Million USD | -2260.142% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -427.926% |
| AEON Biopharma, Inc. | 48.42 Million USD | -2608.786% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -1256.466% |
| Sesen Bio, Inc. | 78.38 Million USD | -1573.668% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -1470.518% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -10322.252% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -190.878% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -1392.591% |
| Athira Pharma, Inc. | 125.46 Million USD | -945.573% |
| Vaccinex, Inc. | 23.45 Million USD | -5492.999% |
| HCW Biologics Inc. | 21.02 Million USD | -6138.672% |
| XOMA Corporation | 46.46 Million USD | -2723.404% |
| Nektar Therapeutics | 190.9 Million USD | -587.175% |
| Arvinas, Inc. | 480 Million USD | -173.3% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -57589.327% |
| Merus N.V. | 200.49 Million USD | -554.303% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -1169.255% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -3689.249% |
| Rezolute, Inc. | 70.38 Million USD | -1763.75% |
| Clene Inc. | 41.07 Million USD | -3093.918% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -7909.525% |
| BeyondSpring Inc. | 24.86 Million USD | -5175.842% |
| Synlogic, Inc. | 58.53 Million USD | -2141.232% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -7231.981% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -29103.874% |
| Peak Bio, Inc. | 1249.13 USD | -105020034.013% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -2070.264% |
| Krystal Biotech, Inc. | 160.42 Million USD | -717.722% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -384.733% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -276.924% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -60725.211% |
| MannKind Corporation | 125.59 Million USD | -944.482% |
| Ikena Oncology, Inc. | 84.57 Million USD | -1451.058% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -13498.404% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -1364.089% |
| Gossamer Bio, Inc. | 183.75 Million USD | -613.89% |
| CohBar, Inc. | 12.38 Million USD | -10489.333% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -2486.227% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -4656.138% |
| Legend Biotech Corporation | 583.14 Million USD | -124.959% |
| Mural Oncology plc | 192.07 Million USD | -582.996% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -1853.681% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -8025.215% |
| Disc Medicine, Inc. | 91.12 Million USD | -1339.603% |
| Champions Oncology, Inc. | 28.11 Million USD | -4566.802% |
| REGENXBIO Inc. | 321.15 Million USD | -308.472% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -24368.956% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -2252.819% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -3267.085% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -1047.143% |
| Vaxart, Inc. | 90.72 Million USD | -1345.934% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -15297.145% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -2965.466% |
| Cellectis S.A. | 97.32 Million USD | -1247.963% |
| Longeveron Inc. | 21.25 Million USD | -6073.355% |
| Repare Therapeutics Inc. | 167.35 Million USD | -683.856% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 3.599% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -1634.203% |
| Revolution Medicines, Inc. | 498.76 Million USD | -163.017% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -19620.956% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -2884.57% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -1658.732% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -1783.877% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -11761.103% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 72.527% |
| Denali Therapeutics Inc. | 527.23 Million USD | -148.817% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -15054.082% |
| Veru Inc. | 101.34 Million USD | -1194.388% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -5504.469% |
| Cingulate Inc. | 22.75 Million USD | -5663.993% |
| Passage Bio, Inc. | 108.38 Million USD | -1110.305% |
| Context Therapeutics Inc. | 25.07 Million USD | -5132.154% |
| Exicure, Inc. | 14.07 Million USD | -9219.679% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -536.617% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -2929.579% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -14194.394% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -419.575% |
| Nuvalent, Inc. | 149.49 Million USD | -777.531% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -16161.98% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -1165.642% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -6016.08% |
| OmniAb, Inc. | 83.89 Million USD | -1463.666% |
| Anew Medical, Inc. | 1.3 Million USD | -100745.376% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -3903.901% |
| Lipocine Inc. | 15.08 Million USD | -8599.111% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -1814.729% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -1622.657% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -3154.026% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -1042.288% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -5760.606% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -97.523% |
| Ocugen, Inc. | 71.56 Million USD | -1733.021% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -1297.565% |
| Q32 Bio Inc. | 92.68 Million USD | -1315.449% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -6095.513% |
| Alumis Inc. Common Stock | 158.17 Million USD | -729.364% |
| Equillium, Inc. | 50.6 Million USD | -2492.258% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -2002.102% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -9333.913% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -6853.779% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -2694.058% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -1109.446% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -10485.547% |
| Dominari Holdings Inc. | 23.83 Million USD | -5403.831% |
| Edesa Biotech, Inc. | 9.22 Million USD | -14123.923% |
| vTv Therapeutics Inc. | 11.9 Million USD | -10917.368% |
| Bio-Techne Corporation | 563.03 Million USD | -132.992% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -220.895% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -388.115% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -891.736% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -9003.032% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -701.387% |
| Nkarta, Inc. | 131.65 Million USD | -896.459% |
| BioCardia, Inc. | 12.12 Million USD | -10722.853% |
| Iterum Therapeutics plc | 47.46 Million USD | -2663.626% |